Cargando…

Development of T cell immunity to norovirus and rotavirus in children under five years of age

Most of the research effort to understand protective immunity against norovirus (NoV) has focused on humoral immunity, whereas immunity against another major pediatric enteric virus, rotavirus (RV), has been studied more thoroughly. The aim of this study was to investigate development of cell-mediat...

Descripción completa

Detalles Bibliográficos
Autores principales: Malm, Maria, Hyöty, Heikki, Knip, Mikael, Vesikari, Timo, Blazevic, Vesna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6397277/
https://www.ncbi.nlm.nih.gov/pubmed/30824789
http://dx.doi.org/10.1038/s41598-019-39840-9
_version_ 1783399398265323520
author Malm, Maria
Hyöty, Heikki
Knip, Mikael
Vesikari, Timo
Blazevic, Vesna
author_facet Malm, Maria
Hyöty, Heikki
Knip, Mikael
Vesikari, Timo
Blazevic, Vesna
author_sort Malm, Maria
collection PubMed
description Most of the research effort to understand protective immunity against norovirus (NoV) has focused on humoral immunity, whereas immunity against another major pediatric enteric virus, rotavirus (RV), has been studied more thoroughly. The aim of this study was to investigate development of cell-mediated immunity to NoV in early childhood. Immune responses to NoV GI.3 and GII.4 virus-like particles and RV VP6 were determined in longitudinal blood samples of 10 healthy children from three months to four years of age. Serum IgG antibodies were measured using enzyme-linked immunosorbent assay and production of interferon-gamma by peripheral blood T cells was analyzed by enzyme-linked immunospot assay. NoV-specific T cells were detected in eight of 10 children by the age of four, with some individual variation. T cell responses to NoV GII.4 were higher than those to GI.3, but these responses were generally lower than responses to RV VP6. In contrast to NoV-specific antibodies, T cell responses were transient in nature. No correlation between cell-mediated and antibody responses was observed. NoV exposure induces vigorous T cell responses in children under five years of age, similar to RV. A role of T cells in protection from NoV infection in early childhood warrants further investigation.
format Online
Article
Text
id pubmed-6397277
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-63972772019-03-05 Development of T cell immunity to norovirus and rotavirus in children under five years of age Malm, Maria Hyöty, Heikki Knip, Mikael Vesikari, Timo Blazevic, Vesna Sci Rep Article Most of the research effort to understand protective immunity against norovirus (NoV) has focused on humoral immunity, whereas immunity against another major pediatric enteric virus, rotavirus (RV), has been studied more thoroughly. The aim of this study was to investigate development of cell-mediated immunity to NoV in early childhood. Immune responses to NoV GI.3 and GII.4 virus-like particles and RV VP6 were determined in longitudinal blood samples of 10 healthy children from three months to four years of age. Serum IgG antibodies were measured using enzyme-linked immunosorbent assay and production of interferon-gamma by peripheral blood T cells was analyzed by enzyme-linked immunospot assay. NoV-specific T cells were detected in eight of 10 children by the age of four, with some individual variation. T cell responses to NoV GII.4 were higher than those to GI.3, but these responses were generally lower than responses to RV VP6. In contrast to NoV-specific antibodies, T cell responses were transient in nature. No correlation between cell-mediated and antibody responses was observed. NoV exposure induces vigorous T cell responses in children under five years of age, similar to RV. A role of T cells in protection from NoV infection in early childhood warrants further investigation. Nature Publishing Group UK 2019-03-01 /pmc/articles/PMC6397277/ /pubmed/30824789 http://dx.doi.org/10.1038/s41598-019-39840-9 Text en © The Author(s) 2019 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Malm, Maria
Hyöty, Heikki
Knip, Mikael
Vesikari, Timo
Blazevic, Vesna
Development of T cell immunity to norovirus and rotavirus in children under five years of age
title Development of T cell immunity to norovirus and rotavirus in children under five years of age
title_full Development of T cell immunity to norovirus and rotavirus in children under five years of age
title_fullStr Development of T cell immunity to norovirus and rotavirus in children under five years of age
title_full_unstemmed Development of T cell immunity to norovirus and rotavirus in children under five years of age
title_short Development of T cell immunity to norovirus and rotavirus in children under five years of age
title_sort development of t cell immunity to norovirus and rotavirus in children under five years of age
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6397277/
https://www.ncbi.nlm.nih.gov/pubmed/30824789
http://dx.doi.org/10.1038/s41598-019-39840-9
work_keys_str_mv AT malmmaria developmentoftcellimmunitytonorovirusandrotavirusinchildrenunderfiveyearsofage
AT hyotyheikki developmentoftcellimmunitytonorovirusandrotavirusinchildrenunderfiveyearsofage
AT knipmikael developmentoftcellimmunitytonorovirusandrotavirusinchildrenunderfiveyearsofage
AT vesikaritimo developmentoftcellimmunitytonorovirusandrotavirusinchildrenunderfiveyearsofage
AT blazevicvesna developmentoftcellimmunitytonorovirusandrotavirusinchildrenunderfiveyearsofage